Drugs / Tirfostina
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05487781 | May → Jun 2022 | — | Molecule X LLC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tirfostina | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05487781 ↗ |
| Route | Oral | “solid oral formulations” NCT05487781 ↗ |